BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26222083)

  • 1. Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment.
    Batista A; Riedemann L; Vardam T; Jain RK
    Cancer J; 2015; 21(4):307-13. PubMed ID: 26222083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic therapy in brain tumors.
    Lakka SS; Rao JS
    Expert Rev Neurother; 2008 Oct; 8(10):1457-73. PubMed ID: 18928341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
    Kepes JJ
    Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiangiogenesis: biology and utility in the treatment of gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336
    [No Abstract]   [Full Text] [Related]  

  • 6. Adhesion molecules and the extracellular matrix as drug targets for glioma.
    Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
    Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?
    Sie M; den Dunnen WF; Hoving EW; de Bont ES
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):418-32. PubMed ID: 24169416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiology and vascular targeting in glioma.
    Short SC; Harney J
    Curr Opin Neurol; 2003 Dec; 16(6):651-5. PubMed ID: 14624072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of the glioma microenvironment].
    Herrlinger U; Platten M
    Nervenarzt; 2015 Jun; 86(6):684, 686-8, 690-1. PubMed ID: 25962344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions that induce modifications in the tumor microenvironment.
    Bernhard EJ
    Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF inhibitors in brain tumors.
    Brastianos PK; Batchelor TT
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):753-60, 768. PubMed ID: 20075834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
    Perry JR
    Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.